Previous 10 | Next 10 |
HAUPPAUGE, N.Y., May 11, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI) (“Chembio”), a leading point-of-care diagnostic company focused on infectious diseases, announced today the closing of its previously announced public offering of 2,619,593 shares o...
MicroVision (NASDAQ: MVIS ) -24% . More news on: MicroVision, Inc., Vista Outdoor Inc., SG Blocks, Inc., Stocks on the move, , Read more ...
Chembio Diagnostics (NASDAQ: CEMI ) prices its public offering of ~2.3M common shares at $11.75 per share. More news on: Chembio Diagnostics, Inc., Healthcare stocks news, , Stocks on the move, Read more ...
HAUPPAUGE, N.Y., May 07, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI) (“Chembio”), a leading point-of-care diagnostic company focused on infectious diseases, announced today the pricing of its previously announced public offering of 2,338,468 shares o...
Portola Pharmaceuticals (NASDAQ: PTLA ) +131% on being acquired for $18/share. More news on: Portola Pharmaceuticals, Inc., SG Blocks, Inc., MicroVision, Inc., Stocks on the move, , Read more ...
Chembio Diagnostics (NASDAQ: CEMI ) announced Q1 results after the close yesterday that missed views , but investors are reacting to its update on activities related to its DPP COVID-19 IgM/IgG blood test that it recently launched. Key developments: More news on: Chembio Diagnostics, In...
Chembio Diagnostics, Inc. (CEMI) Q1 2020 Earnings Conference Call May 4, 2020, 04:30 PM ET Company Participants Philip Taylor - IR Gail Page - Chairman Rick Eberly - President & CEO Neil Goldman - CFO Javan Esfandiari - Chief Product and Technology Officer Conference C...
Chembio Diagnostics (NASDAQ: CEMI ): Q1 GAAP EPS of -$0.29 misses by $0.06 . More news on: Chembio Diagnostics, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...
HAUPPAUGE, N.Y., May 04, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today reported financial results for the quarter ended March 31, 2020. Recent Accomplishments & Highlights Atta...
HAUPPAUGE, N.Y., May 04, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced it has attained the CE Marking for its DPP COVID-19 System. The CE Marking represents the ability to co...
News, Short Squeeze, Breakout and More Instantly...
Chembio Diagnostics Inc. Company Name:
CEMI Stock Symbol:
NASDAQ Market:
Chembio Diagnostics Inc. Website:
Chembio Diagnostics, Inc. becomes the first North American structure controlled by Biosynex in North America STRASBOURG, France, April 27, 2023 (GLOBE NEWSWIRE) -- Biosynex SA (“Biosynex”) (EPA: ALBIO), a French market leader specializing in the design and distribution of ...
MEDFORD, N.Y., April 19, 2023 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today released the following letter to stockholders concerning the pending tender offer by Biosynex SA. April 19, 2023 ...
MEDFORD, N.Y., April 10, 2023 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today released the following letter to stockholders concerning the pending tender offer by Biosynex SA. April 10, 2023 ...